- Bedoelde u
- arnaud marchand
Zoekresultaten - 13 results
Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaksAbstract
Bours, Vincent; Gourzonès, Claire; Ek, Olivier; Bureau, Fabrice; Kabamba, Benoît; Gala, Jean-Luc; Bearzatto, Bertrand; Ambroise, Jérôme; Marchant, Arnaud; Henin, Coralie; Haerlingen, Benoit; De Mendonca, ...
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Lemy, Anne; Maria Goossens; I Desombere; Michiels, Johan; Vandevenne, Marylène; Heyndrickx, Leo; Ariën, Kevin K; Matagne, André; Ackerman, Margaret E; Le Moine, Alain; Marchant, Arnaud Source: Am ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Verbrugghe, Mathieu; Van Loon, Nele; Dierick, Katelijne; Matagne, André; Desombere, Isabelle; Ariën, Kevin K; Marchant, Arnaud; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Keywords: Adult ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
Verbrugghe, Mathieu; Van Loon, Nele; Dierick, Katelijne; Matagne, André; I Desombere; Ariën, Kevin K.; Marchant, Arnaud; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Health Topics: Health and ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
Stéphane De Craeye; Antoine Francotte; Félicie Chaumont; Véronique Olislagers; Alexandra Waegemans; Mathieu Verbrugghe; Marie-Noëlle Schmickler; Steven Van Gucht; Katelijne Dierick; Arnaud Marchant ...
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
Publication Type: Peer reviewed scientific article Authors: Frédéric Baron; Lorenzo Canti; Ariën, Kevin K; Delphine Kemlin; I Desombere; Margaux Gerbaux; Pieter Pannus; Yves Beguin; Arnaud Marchant ...
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.
Evelyne Willems; Grégory Ehx; Stanislas Goriely; Laurence Seidel; Johan Michiels; Betty Willems; Maria Goossens; Yves Beguin; Arnaud Marchant; Frédéric Baron Source: Cancer Cell, Volume 40, Issue 4 (2022) ...
Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19.
Orte Cano; Véronique Del Marmol; Pieter Pannus; Frédérick Libert; Sven Saussez; Nicolas Dauby; Jishnu Das; Arnaud Marchant; Stanislas Goriely Source: JCI Insight, Volume 7, Issue 9 (2022) Keywords: ...
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
A Martens; Van Esbroeck, Marjan; Maria Goossens; Arnaud Marchant; Koen Bartholomeeusen; I Desombere Source: NPJ Vaccines, Volume 7, Issue 1 (2022) Abstract: We report the levels of neutralising antibodies ...
Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients.
Publication Type: Peer reviewed scientific article Authors: Delphine Kemlin; Anne Lemy; Pieter Pannus; I Desombere; Nicolas Gemander; Maria Goossens; Arnaud Marchant; Le Moine, Alain Source: Am ...